BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cosi C, Martel JC, Auclair AL, Collo G, Cavalleri L, Heusler P, Leriche L, Gaudoux F, Sokoloff P, Moser PC, Gatti-McArthur S. Pharmacology profile of F17464, a dopamine D3 receptor preferential antagonist. Eur J Pharmacol 2021;890:173635. [PMID: 33065094 DOI: 10.1016/j.ejphar.2020.173635] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Lee A, Choo H, Jeon B. Serotonin Receptors as Therapeutic Targets for Autism Spectrum Disorder Treatment. Int J Mol Sci 2022;23:6515. [PMID: 35742963 DOI: 10.3390/ijms23126515] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kiss B, Krámos B, Laszlovszky I. Potential Mechanisms for Why Not All Antipsychotics Are Able to Occupy Dopamine D3 Receptors in the Brain in vivo. Front Psychiatry 2022;13:785592. [DOI: 10.3389/fpsyt.2022.785592] [Reference Citation Analysis]
3 Murayama C, Iwabuchi T, Kato Y, Yokokura M, Harada T, Goto T, Tamayama T, Kameno Y, Wakuda T, Kuwabara H, Senju A, Nishizawa S, Ouchi Y, Yamasue H. Extrastriatal dopamine D2/3 receptor binding, functional connectivity, and autism socio-communicational deficits: a PET and fMRI study. Mol Psychiatry 2022. [PMID: 35181754 DOI: 10.1038/s41380-022-01464-3] [Reference Citation Analysis]
4 Sato A, Kotajima-murakami H, Tanaka M, Katoh Y, Ikeda K. Influence of Prenatal Drug Exposure, Maternal Inflammation, and Parental Aging on the Development of Autism Spectrum Disorder. Front Psychiatry 2022;13:821455. [DOI: 10.3389/fpsyt.2022.821455] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Mandic-maravic V, Grujicic R, Milutinovic L, Munjiza-jovanovic A, Pejovic-milovancevic M. Dopamine in Autism Spectrum Disorders—Focus on D2/D3 Partial Agonists and Their Possible Use in Treatment. Front Psychiatry 2022;12:787097. [DOI: 10.3389/fpsyt.2021.787097] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Torrisi SA, Geraci F, Contarini G, Salomone S, Drago F, Leggio GM. Dopamine D3 Receptor, Cognition and Cognitive Dysfunctions in Neuropsychiatric Disorders: From the Bench to the Bedside. Current Topics in Behavioral Neurosciences 2022. [DOI: 10.1007/7854_2022_326] [Reference Citation Analysis]
7 Sokoloff P, Le Foll B. A Historical Perspective on the Dopamine D3 Receptor. Current Topics in Behavioral Neurosciences 2022. [DOI: 10.1007/7854_2022_315] [Reference Citation Analysis]
8 Lobo MC, Whitehurst TS, Kaar SJ, Howes OD. New and emerging treatments for schizophrenia: a narrative review of their pharmacology, efficacy and side effect profile relative to established antipsychotics. Neurosci Biobehav Rev 2021;132:324-61. [PMID: 34838528 DOI: 10.1016/j.neubiorev.2021.11.032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
9 Cosi C, Millar M, Beltran M, Sherry L, Gatti-McArthur S. Quantitative analysis of RNAscope staining for c-fos expression in mouse brain tissue as a measure of Neuronal Activation. MethodsX 2021;8:101348. [PMID: 34430251 DOI: 10.1016/j.mex.2021.101348] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Román V, Adham N, Foley AG, Hanratty L, Farkas B, Lendvai B, Kiss B. Cariprazine alleviates core behavioral deficits in the prenatal valproic acid exposure model of autism spectrum disorder. Psychopharmacology (Berl) 2021;238:2381-92. [PMID: 34264367 DOI: 10.1007/s00213-021-05851-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
11 Kiss B, Laszlovszky I, Krámos B, Visegrády A, Bobok A, Lévay G, Lendvai B, Román V. Neuronal Dopamine D3 Receptors: Translational Implications for Preclinical Research and CNS Disorders. Biomolecules 2021;11:104. [PMID: 33466844 DOI: 10.3390/biom11010104] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 16.0] [Reference Citation Analysis]